Portfolio Companies

---

Dosentrx delivers the precision of inpatient medication management in an outpatient setting. Through unparalleled engagement, support, communication and supervision, Dosentrx is focused on unlocking the key to better patient care and better outcomes.

"We truly valued Engage’s partnership on this important funding round. The Engage team is thorough and experienced, and it was especially helpful to hear their perspective and feedback on our positioning. Engage and their investors are helping Dosentrx realize its mission of transforming remote specialty pharmaceutical care." -Mark Summers, Executive Chairman Dosentrx

VOCxi Health is a breath diagnostics company focused on accurate, non-invasive, real-time, mobile disease identification to enable early detection and make late-stage disease diagnoses a thing of the past. 

"Fundraising is one of the most important efforts for a startup, and I am so pleased with how Engage led our development funding round. Their knowledge and thoughtful advice was extremely helpful as we approached our fundraising. Through their strong network of highly engaged investors, they contributed a significant portion of this first round, and we are thrilled to have Morgan Evans from Engage join our Board of Directors.” -Ping Yeh, CEO VOCxi Health 

Agitated Solutions is reimagining ultrasound contrast. Designed by a physician to improve workflow efficiency, the revolutionary Orbis™ microbubble generator delivers consistent, high-density bubbles with extended duration.

"I feel fortunate to have worked with Engage on our fundraise. The SPV model allows for collaboration on so many levels — it is incredibly founder- and investor-friendly. The Engage team and our new investors helped us get to the goal line to complete this important round of financing, which will fund the commercial launch of our first product and allow us to continue developing innovative new offerings.” -Morgan Evans, CEO Agitated Solutions 

Melodi Health is developing a novel absorbable scaffold intended to support soft tissue and improve patient outcomes.   

“The Engage team pulled together a group of mature angel investors that aligned with our timeline and investment stage who were uniquely qualified to invest in our platform including surgeons and seasoned medtech investors. The Engage SPV was an efficient, well-organized way for Melodi to raise a meaningful amount of capital that significantly funds our pre-commercial development activities aimed at impacting outcomes for women with breast cancer undergoing post-mastectomy reconstruction on their journey to recovery.” - Sarah Worrell, CEO Melodi Health